Acute inhibition of lipolysis does not affect postprandial suppression of endogenous glucose production

American Journal of Physiology - Endocrinology and Metabolism

Volumn 289, Issue 6, 2005, Pages

  Carey, Peter E ^a   Gerrard, Jean ^a   Cline, Gary W ^c   Dalla Man, Chiara ^d   English, Philip T ^b   Firbank, Michael J ^a   Cobelli, Claudio ^d   Taylor, Roy ^a,e  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b ROYAL VICTORIA INFIRMARY   (United Kingdom)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF PADOVA   (Italy)

^e NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

1H magnetic resonance spectroscopy; Acipimox; Intrahepatic triglyceride

Indexed keywords

3 HYDROXYBUTYRIC ACID; ACIPIMOX; ALANINE; C PEPTIDE; FATTY ACID; GLUCAGON; GLUCOSE; GLYCEROL; INSULIN; LACTIC ACID; TRIACYLGLYCEROL; ANTILIPEMIC AGENT; PLACEBO; PYRAZINE DERIVATIVE;

ADULT; ARTICLE; CONTROLLED STUDY; DEUTERON NUCLEAR MAGNETIC RESONANCE; FEMALE; FOOD INTAKE; GLUCONEOGENESIS; GLUCOSE BLOOD LEVEL; HUMAN; HUMAN EXPERIMENT; INSULIN BLOOD LEVEL; LACTATE BLOOD LEVEL; LIPOLYSIS; MALE; NORMAL HUMAN; OXIDATION; POSTPRANDIAL STATE; PRIORITY JOURNAL; STEADY STATE; BIOSYNTHESIS; BLOOD; CHEMISTRY; DRUG EFFECT; FOOD; KINETICS; LIVER; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; OXIDATION REDUCTION REACTION;

ADULT; ANTILIPEMIC AGENTS; BLOOD GLUCOSE; C-PEPTIDE; FATTY ACIDS, NONESTERIFIED; FEMALE; FOOD; GLUCAGON; GLUCOSE; GLYCEROL; HUMANS; INSULIN; KINETICS; LIPOLYSIS; LIVER; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED; OXIDATION-REDUCTION; PLACEBOS; PYRAZINES; TRIGLYCERIDES;

EID: 33644687893     PISSN: 01931849     EISSN: 15221555     Source Type: Journal    
DOI: 10.1152/ajpendo.00195.2005     Document Type: Article

References (29)

1. Bajaj M, Suraamornkul S, Pratipanawatr T, Hardies LJ, Pratipanawatr W, Glass L, Cersosimo E, Miyazaki Y, and DeFronzo RA. Pioglitazone reduces hepatic fat content and augments splanchnic glucose uptake in patients with type 2 diabetes. Diabetes 52: 1364-1370, 2003.
2. Boden G, Cheung P, Stein TP, Kresge K, and Mozzoli M. FFA cause hepatic insulin resistance by inhibiting insulin suppression of glycogenolysis. Am J Physiol Endocrinol Metab 283: E12-E19, 2002.
3. Boesch C, Slotboom J, Hoppeler H, and Kreis R. In vivo determination of intra-myocellular lipids in human muscle by means of localized 1HMR-spectroscopy. Magn Reson Med 37: 484-493, 1997.
4. Bottomley PA. Spatial localization in NMR spectroscopy in vivo. Ann NY Acad Sci 508: 333-348, 1987.
5. Cobelli C, Foster D, and Toffolo G. Tracer Kinetics in Biomedical Research: From Data to Model. New York: Kluwer Academic/Plenum, 2000.
6. Cobelli C and Toffolo G. Constant specific activity input allows reconstruction of endogenous glucose concentration in non-steady state. Am J Physiol Endocrinol Metab 258: E1037-E1040, 1990.
7. Flechtner-Mors M, Jenkinson CP, Alt A, Alder G, and Ditschuneit HH. Effect of acipimox on the lipolysis rate in subcutaneous adipose tissue of obese subjects. Diabetes Metab Res Rev 17: 387-390, 2001.
8. Frayn KN. Calculation of substrate oxidation rates in vivo from gaseous exchange. J Appl Physiol 55: 628-34, 1983.
9. Fulcher GR, Walker M, Catalano C, Agius L, and Alberti KG. Metabolic effects of suppressions of nonesterified fatty acid levels with acipimox in obese NIDDM subjects. Diabetes 41: 1400-1408, 1992.
10. Gastaldelli A, Miyazaki Y, Pettiti M, Matsuda M, Mahankali S, Santini E, DeFronzo RA, and Ferrannini E. Metabolic effects of visceral fat accumulation in type 2 diabetes. J Clin Endocrinol Metab 87: 5098-5103, 2002.
11. Gupta G, Cases JA, She L, Ma XH, Yang XM, Hu M, Wu J, Rossetti L, and Barzilai N. Ability of insulin to modulate hepatic glucose production in aging rats is impaired by fat accumulation. Am J Physiol Endocrinol Metab 278: E985-E991, 2000.
12. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, and Turner R. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin. Diabetologia 28: 412-419, 1985.
13. Naressi A, Couturier C, Castang I, de Beer R, and Graveron-Demilly D. Java-based graphical user interface for MRUI, a software package for quantitation of in vivo/medical magnetic resonance spectroscopy signals. Comput Biol Med 31: 269-286, 2001.
14. Petersen KF, Dufour S, Befroy D, Lehrke M, Hendler RE, and Shulman GI. Reversal of nonalcoholic hepatic steatosis, hepatic insulin resistance, and hyperglycemia by moderate weight reduction in patients with type 2 diabetes. Diabetes 54: 603-608, 2005.
15. Radziuk J, Norwich KH, and Vranic M. Experimental validation of measurements of glucose turnover in nonsteady state. Am J Physiol Endocrinol Metab Gastrointest Physiol 234: E84-E93, 1978.
16. Ryysy L, Hakkinen AM, Goto T, Vehkavaara S, Westerbacka J, Halavaara J, and Yki-Jarvinen H. Hepatic fat content and insulin action on free fatty acids and glucose metabolism rather than insulin absorption are associated with insulin requirements during insulin therapy in type 2 diabetic patients. Diabetes 49: 749-758, 2000.
17. Saloranta C, Groop L, Ekstrand A, Franssila-Kallunki A, Eriksson J, and Taskinen MR. Different acute and chronic effects of acipimox treatment on glucose and lipid metabolism in patients with type 2 diabetes. Diabet Med 10: 950-957, 1993.
18. Saloranta C, Groop LC, Ekstrand A, Franssila-Kallunki A, and Taskinen MR. The effect of an antilipolytic agent (acipimox) on the insulin resistance of lipid and glucose metabolism in hypertriglyceridaemic patients. Acta Diabetol 31: 6-13, 1994.
19. Segerlantz M, Bramnert M, Manhem P, Laurila E, and Groop LC. Inhibition of the rise in FFA by Acipimox partially prevents GH-induced insulin resistance in GH-deficient adults. J Clin Endocrinol Metab 86: 5813-5818, 2001.
20. Shurbaji A al, Berglund L, and Bjorkhem I. The effect of Acipimox on triacylglycerol metabolism in rat. Scand J Clin Lab Invest 50: 203-208, 1990.
21. Singhal P, Caumo A, Cobelli C, and Taylor R. Effect of repaglinide, and glicizide on postprandial control of endogenous glucose production. Metabolism 54: 79-84, 2005.
22. Sparacino G, Pillonetto G, Capello M, De Nicolao G, and Cobelli C. WINSTODEC: a stochastic deconvolution interactive program for physiological and pharmaceutical systems. Comput Methods Programs Biomed 76: 67-77, 2002.
23. Stirling C, McAleer M, Reckless JP, Campbell RR, Mundy D, Betteridge DJ, and Foster K. Effects of acipimox, a nicotinic acid derivative, on lipolysis in human adipose tissue and cholesterol synthesis in human jejunal mucosa. Clin Sci (Lond) 68: 83-88, 1985.
24. Szczepaniak LS, Babcock EE, Schick F, Dobbins RL, Garg A, Burns DK, McGarry JD, and Stein DT. Measurement of intracellular triglyceride stores by H. spectroscopy: validation in vivo. Am J Physiol Endocrinol Metab 276: E977-E989, 1999.
25. Taylor R, Magnusson I, Rothman DL, Cline GW, Caumo A, Cobelli C, and Shulman GI. Direct assessment of liver glycogen storage by 13C nuclear magnetic resonance spectroscopy and regulation of glucose homeostasis after a mixed meal in normal subjects. J Clin Invest 97: 126-132, 1996.
26. Taylor R, Price TB, Katz LD, Shulman RG, and Shulman GI. Direct measurement of change in muscle glycogen concentration after a mixed meal in normal subjects. Am J Physiol Endocrinol Metab 265: E224-E229, 1993.
27. Tiikkainen M, Tamminen M, Hakkinen AM, Bergholm R, Vehkavaara S, Halavaara J, Teramo K, Rissanen A, and Yki-Jarvinen H. Liver-fat accumulation and insulin resistance in obese women with previous gestational diabetes. Obes Res 10: 859-867, 2002.
28. Vaag A, Skott P, Damsbo P, Gall MA, Richter EA, and Beck-Nielsen H. Effect of the antilipolytic nicotinic acid analog acipimox on whole-body and skeletal muscle glucose metabolism in patients with noninsulin-dependent diabetes mellitus. J Clin Invest 88: 1282-1290, 1991.
29. Wolfe RR. Radioactive and Stable Isotope Traces in Biomedicine: Principles and Practice of Kinetic Analysis. New York: Wiley-Liss, 1992.